A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Takashi Shimada, Eric Tran et al.|The Analyst|2022Cited by 5
8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibodyNoriko Iwamoto, Takashi Shimada, Yoshinobu Koguchi et al.|Regular and Young Investigator Award Abstracts|2022Cited by 1
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Takashi Shimada, William L. Redmond et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0